| 5561 |
The angiotensin-converting enzyme insertion/deletion polymorphism of Vitiligo in Upper Egypt population: A hospital based study. |
Department of Dermatology |
2016 |
| 5562 |
The angiotensin-converting enzyme insertion/deletion polymorphism of Vitiligo in Upper Egypt population: A hospital based study. |
Department of Dermatology |
2016 |
| 5563 |
The concepts of propeller, perforator, keystone, and other local flaps and their role in the evolution of reconstruction |
Department of Orthopedic Surgery and Traumatology |
2016 |
| 5564 |
The correlation between Aflatoxin B1 and Placental Apoptosis in Pregnant women with Intrauterine Growth Restriction |
Department of Biochemistry |
2016 |
| 5565 |
The effect of magnesium therapy to prevent post-operative atrial fibrillation after cardiac surgery in adults, concerning the perioperative changes in serum electrolytes. |
Department of Anesthesia and Intensive Care |
2016 |
| 5566 |
The effect of magnesium therapy to prevent post-operative atrial fibrillation after cardiac surgery in adults, concerning the perioperative changes in serum electrolytes. |
Department of Anesthesia and Intensive Care |
2016 |
| 5567 |
The Effect of Magnesium Therapy to Prevent Post-Operative Atrial Fibrillation After
Cardiac Surgery in Adults Concerning the Perioperative Changes in Serum
Electrolytes.
|
Department of Anesthesia and Intensive Care |
2016 |
| 5568 |
The Effect of Magnesium Therapy to Prevent Post-Operative Atrial Fibrillation After
Cardiac Surgery in Adults Concerning the Perioperative Changes in Serum
Electrolytes.
|
Department of Anesthesia and Intensive Care |
2016 |
| 5569 |
The first perforating branch of the deep femoral artery: A reliable recipient vessel for vascularized fibular grafts: An anatomical study |
Department of Orthopedic Surgery and Traumatology |
2016 |
| 5570 |
The Impact of Capecitabine and Oxaliplatin in the Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer |
Department of Rheumatology ,Rehabilitation & physical medicine |
2016 |
Do you have any questions? 
